Inflammatory marker changes in a yearlong randomized exercise intervention trial among postmenopausal women

Cancer Prevention Research

Volumn 5, Issue 1, 2012, Pages 98-108

  Friedenreich, Christine M ^a   Neilson, Heather K ^a   Woolcott, Christy G ^d   Wang, Qinggang ^a   Stanczyk, Frank Z ^e   McTiernan, Anne ^f   Jones, Charlotte A ^b   Irwin, Melinda L ^g   Yasui, Yutaka ^c   Courneya, Kerry S ^c  

^a ALBERTA HEALTH SERVICES   (Canada)

^b UNIVERSITY OF CALGARY   (Canada)

^c UNIVERSITY OF ALBERTA   (Canada)

^d DALHOUSIE UNIVERSITY   (Canada)

^e UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

^f Fred Hutchinson Cancer Research Center   (United States)

^g YALE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

C REACTIVE PROTEIN; INTERLEUKIN 6; TUMOR NECROSIS FACTOR ALPHA ANTIBODY;

ADULT; AEROBIC EXERCISE; AGED; ARTICLE; BREAST CANCER; CHEMOLUMINESCENCE; CONTROLLED STUDY; DIETARY FIBER; DIETARY INTAKE; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; FITNESS; HUMAN; HUMAN EXPERIMENT; IMMOBILIZATION; IMMUNOASSAY; INFLAMMATION; NORMAL HUMAN; POSTMENOPAUSE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL;

AGED; ANTHROPOMETRY; BREAST NEOPLASMS; C-REACTIVE PROTEIN; DIET; ENZYME-LINKED IMMUNOSORBENT ASSAY; EXERCISE; FEMALE; HUMANS; INFLAMMATION; INTERLEUKIN-6; MIDDLE AGED; MODELS, STATISTICAL; POSTMENOPAUSE; RANDOMIZED CONTROLLED TRIALS AS TOPIC; RISK FACTORS; TUMOR NECROSIS FACTOR-ALPHA;

EID: 84862939604     PISSN: 19406207     EISSN: 19406215     Source Type: Journal    
DOI: 10.1158/1940-6207.CAPR-11-0369     Document Type: Article

References (54)

1. Eklund CM. Proinflammatory cytokines in CRP baseline regulation. Adv Clin Chem 2009;48:111-36.
2. Willerson JT, Ridker PM. Inflammation as a cardiovascular risk factor. Circulation 2004;109:II2-10.
3. Colotta F, Allavena P, Sica A, Garlanda C, Mantovani A. Cancer-related inflammation, the seventh hallmark of cancer: links to genetic instability. Carcinogenesis 2009;30:1073-81.
4. Grivennikov SI, Karin M. Inflammation and oncogenesis: a vicious connection. Curr Opin Genet Dev 2010;20:65-71.
5. Heikkila K, Ebrahim S, Lawlor DA. A systematic review of the association between circulating concentrations of C reactive protein and cancer. J Epidemiol Community Health 2007;61:824-33.
6. Harris RE, Chlebowski RT, Jackson RD, Frid DJ, Ascenseo JL, Anderson G, et al. Breast cancer and nonsteroidal anti-inflammatory drugs: prospective results from the Women's Health Initiative. Cancer Res 2003;63:6096-101. (Pubitemid 37187516)
7. Il'yasova D, Colbert LH, Harris TB, Newman AB, Bauer DC, Satterfield S, et al. Circulating levels of inflammatory markers and cancer risk in the health aging and body composition cohort. Cancer Epidemiol Biomarkers Prev 2005;14:2413-8. (Pubitemid 41437845)
8. Siemes C, Visser LE, Coebergh JW, Splinter TA, Witteman JC, Uitterlinden AG, et al. C-reactive protein levels, variation in the C-reactive protein gene, and cancer risk: the Rotterdam Study. J Clin Oncol 2006;24:5216-22. (Pubitemid 46631365)
9. World Cancer Research Fund and the American Institute for Cancer Research. Food, nutrition, physical activity, and the prevention of cancer: a global perspective. Washington, DC: American Institute for Cancer Research; 2007.
10. Lynch BM, Neilson HK, Friedenreich CM. Physical activity and breast cancer prevention. Recent Results Cancer Res 2011;186:13-42.
11. Gleeson M, Bishop NC, Stensel DJ, Lindley MR, Mastana SS, Nimmo MA. The anti-inflammatory effects of exercise: mechanisms and implications for the prevention and treatment of disease. Nat Rev Immunol 2011;11:607-15.
12. Morris PG, Hudis CA, Giri D, Morrow M, Falcone DJ, Zhou XK, et al. Inflammation and increased aromatase expression occur in the breast tissue of obese women with breast cancer. Cancer Prev Res 2011;4:1021-9.
13. Pearson TA, Mensah GA, Alexander RW, Anderson JL, Cannon RO III, Criqui M, et al. Markers of inflammation and cardiovascular disease: application to clinical and public health practice: a statement for healthcare professionals from the Centers for Disease Control and Prevention and the American Heart Association. Circulation 2003;107:499-511. (Pubitemid 36158056)
14. Richards CD, Gauldie J. Role of cytokines in acute phase response. In:Aggarwal BB, Puri RK, editors. Human cytokines: their roles in disease and therapy. Cambridge, MA: Blackwell Science Inc.; 1995. p. 253-69.
15. Petersen AM, Pedersen BK. The anti-inflammatory effect of exercise. J Appl Physiol 2005;98:1154-62. (Pubitemid 40396484)
16. Bruunsgaard H. Physical activity and modulation of systemic low-level inflammation. J Leukoc Biol 2005;78:819-35. (Pubitemid 41384398)
17. Shephard RJ. Cytokine responses to physical activity, with particular reference to IL-6: sources, actions, and clinical implications. Crit Rev Immunol 2002;22:165-82. (Pubitemid 35453702)
18. Kern PA, Ranganathan S, Li C, Wood L, Ranganathan G. Adipose tissue tumor necrosis factor and interleukin-6 expression in human obesity and insulin resistance. Am J Physiol Endocrinol Metab 2001;280:E745-E751.
19. Mohamed-Ali V, Goodrick S, Rawesh A, Katz DR, Miles JM, Yudkin JS, et al. Subcutaneous adipose tissue releases interleukin-6, but not tumor necrosis factor-alpha, in vivo. J Clin Endocrinol Metab 1997;82:4196-200. (Pubitemid 27525539)
20. Warnberg J, Cunningham K, Romeo J, Marcos A. Physical activity, exercise and low-grade systemic inflammation. Proc Nutr Soc 2010;69:400-6.
21. Mora S, Lee IM, Buring JE, Ridker PM. Association of physical activity and body mass index with novel and traditional cardiovascular biomarkers in women. JAMA 2006;295:1412-9.
22. Arsenault BJ, Cote M, Cartier A, Lemieux I, Despres JP, Ross R, et al. Effect of exercise training on cardiometabolic risk markers among sedentary, but metabolically healthy overweight or obese post-menopausal women with elevated blood pressure. Atherosclerosis 2009;207:530-3.
23. Bergstrom I, Lombardo C, Brinck J. Physical training decreases waist circumference in postmenopausal borderline overweightwomen. Acta Obstet Gynecol Scand 2009;88:308-13.
24. Camhi SM, Stefanick ML, Ridker PM, Young DR. Changes in C-reactive protein from low-fat diet and/or physical activity in men and women with and without metabolic syndrome. Metabolism 2010;59:54-61.
25. Campbell PT,Campbell KL,WenerMH,Wood BL, Potter JD,McTiernan A, et al. A yearlong exercise intervention decreases CRP among obese postmenopausal women. Med Sci Sports Exerc 2009;41:1533-9.
26. Kemmler W, Von SS, Engelke K, Kalender WA. Exercise decreases the risk of metabolic syndrome in elderly females. Med Sci Sports Exerc 2009;41:297-305.
27. Stewart LK, Earnest CP, Blair SN, Church TS. Effects of different doses of physical activity on C-reactive protein among women. Med Sci Sports Exerc 2010;42:701-7.
28. Kushner I, Rzewnicki D, Samols D. What does minor elevation of C-reactive protein signify? Am J Med 2006;119:166-28.
29. Lee CG, CarrMC, Murdoch SJ, Mitchell E, Woods NF, Wener MH, et al. Adipokines, inflammation, and visceral adiposity across the menopausal transition: a prospective study. J Clin Endocrinol Metab 2009;94:1104-10.
30. Friedenreich CM, Woolcott CG, McTiernan A, Ballard-Barbash R, Brant RF, Stanczyk FZ, et al. Alberta physical activity and breast cancer prevention trial: sex hormone changes in a year-long exercise intervention among postmenopausal women. J Clin Oncol 2010;28:1458-66.
31. Friedenreich CM, Woolcott CG, McTiernan A, Terry T, Brant R, Ballard- Barbash R, et al. Adiposity changes after a 1-year aerobic exercise intervention among postmenopausal women: a randomized controlled trial. Int J Obes (Lond) 2010;35:427-35.
32. American College of Sports Medicine. ACSM's guidelines for exercise testing and prescription. Philadelphia, PA: Lippincott Williams & Wilkins; 2000.
33. Basu A, Devaraj S, Jialal I. Dietary factors that promote or retard inflammation. Arterioscler Thromb Vasc Biol 2006;26:995-1001. (Pubitemid 43732103)
34. Egger G, Dixon J. Inflammatory effects of nutritional stimuli: further support for the need for a big picture approach to tackling obesity and chronic disease. Obes Rev 2010;11:137-49.
35. Cavicchia PP, Steck SE, Hurley TG, Hussey JR, Ma Y, Ockene IS, et al. A new dietary inflammatory index predicts interval changes in serum high-sensitivity C-reactive protein. J Nutr 2009;139:2365-72.
36. Kraemer HC, Wilson GT, Fairburn CG, Agras WS. Mediators and moderators of treatment effects in randomized clinical trials. Arch Gen Psychiatry 2002;59:877-83.
37. Mackinnon DP, Fairchild AJ. Current directions in mediation analysis. Curr Dir Psychol Sci 2009;18:16.
38. Friedenreich CM, Neilson HK, Woolcott CG, Wang Q, Yasui Y, Brant RF, et al. Mediators and moderators of the effects of a year-long exercise intervention on endogenous sex hormones in postmenopausal women. Cancer Causes Control 2011;22: 1365-73.
39. Ware JE, Sherbourne CD. The MOS 36-item short-form health survey (SF-36). I. Conceptual framework and item selection. Med Care 1992;30:473-83.
40. Kelley GA, Kelley KS. Effects of aerobic exercise on C-reactive protein, body composition, and maximum oxygen consumption in adults: a meta-analysis of randomized controlled trials. Metabolism 2006;55:1500-7. (Pubitemid 44540369)
41. Plaisance EP, Grandjean PW. Physical activity and high-sensitivity Creactive protein. Sports Med 2006;36:443-58.
42. Lakka HM, Lakka TA, Rankinen T, Rice T, Rao DC, Leon AS, et al. The TNF-alpha G-308A polymorphism is associated with C-reactive protein levels: the HERITAGE Family Study. Vascul Pharmacol 2006;44:377-83.
43. Campbell KL, Campbell PT, Ulrich CM, Wener M, Alfano CM, Foster- Schubert K, et al. No reduction in C-reactive protein following a 12- month randomized controlled trial of exercise in men and women. Cancer Epidemiol Biomarkers Prev 2008;17:1714-8.
44. Lee YH, Pratley RE. The evolving role of inflammation in obesity and the metabolic syndrome. Curr Diab Rep 2005;5:70-5. (Pubitemid 40277804)
45. Selvin E, Paynter NP, Erlinger TP. The effect of weight loss on C-reactive protein: a systematic review. Arch Intern Med 2007;167:31-9. (Pubitemid 46072404)
46. Nicklas BJ, You T, Pahor M. Behavioural treatments for chronic systemic inflammation: effects of dietary weight loss and exercise training. CMAJ 2005;172:1199-209. (Pubitemid 40592678)
47. Hamer M. The relative influences of fitness and fatness on inflammatory factors. Prev Med 2007;44:3-11. (Pubitemid 46073084)
48. Astrom MB, Feigh M, Pedersen BK. Persistent low-grade inflammation and regular exercise. Front Biosci 2010;96-105.
49. Straub RH. The complex role of estrogens in inflammation. Endocr Rev 2007;28:521-74. (Pubitemid 47236336)
50. Gilliver SC. Sex steroids as inflammatory regulators. J Steroid Biochem Mol Biol 2010;120:105-15.
51. You T, Berman DM, Ryan AS, Nicklas BJ. Effects of hypocaloric diet and exercise training on inflammation and adipocyte lipolysis in obese postmenopausal women. J Clin Endocrinol Metab 2004;89:1739-46. (Pubitemid 38507928)
52. Flick DA, Gifford GE. Pharmacokinetics of murine tumor necrosis factor. J Immunopharmacol 1986;8:89-97. (Pubitemid 16101525)
53. Heaney ML, Golde DW. Soluble receptors in human disease. J Leukoc Biol 1998;64:135-46. (Pubitemid 28354974)
54. Heikkila K, Harris R, Lowe G, Rumley A, Yarnell J, Gallacher J, et al. Associations of circulating C-reactive protein and interleukin-6 with cancer risk: findings from two prospective cohorts and a meta-analysis. Cancer Causes Control 2009;20:15-26.